Renaissance Technologies - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 117 filers reported holding TG THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,507
-13.6%
1,376,462
+156.7%
0.02%
+5.3%
Q2 2023$13,319
+1036.4%
536,200
+441.1%
0.02%
+850.0%
Q4 2022$1,172
-99.9%
99,100
-44.7%
0.00%0.0%
Q3 2022$1,061,000
-78.9%
179,200
-84.8%
0.00%
-66.7%
Q2 2022$5,020,000
+167.2%
1,181,100
+497.7%
0.01%
+200.0%
Q1 2022$1,879,000
-60.3%
197,600
-20.7%
0.00%
-66.7%
Q4 2021$4,735,000
-16.3%
249,200
+70.9%
0.01%
-14.3%
Q2 2021$5,656,000
-12.4%
145,800
+8.8%
0.01%
-12.5%
Q1 2021$6,459,000
-66.3%
134,000
-63.6%
0.01%
-61.9%
Q4 2020$19,143,000
+625.4%
368,000
+273.2%
0.02%
+600.0%
Q3 2020$2,639,000
-88.3%
98,600
-91.5%
0.00%
-84.2%
Q2 2020$22,507,000
+346.9%
1,155,400
+125.8%
0.02%
+280.0%
Q1 2020$5,036,000
-61.5%
511,800
-56.6%
0.01%
-50.0%
Q4 2019$13,092,000
+2042.7%
1,179,500
+984.2%
0.01%
+900.0%
Q3 2019$611,000
-56.0%
108,794
-32.2%
0.00%0.0%
Q2 2019$1,388,000
+274.1%
160,500
+248.2%
0.00%
Q1 2019$371,000
-89.7%
46,100
-94.7%
0.00%
-100.0%
Q4 2018$3,591,000
+81.9%
875,900
+148.5%
0.00%
+100.0%
Q3 2018$1,974,000
+558.0%
352,500
+1717.1%
0.00%
+100.0%
Q1 2015$300,000
-88.0%
19,399
-87.7%
0.00%
-83.3%
Q4 2014$2,501,000
+2001.7%
157,881
+1309.8%
0.01%
Q3 2014$119,00011,1990.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders